secwatch.observer — SEC 8-K summary
======================================

Issuer:     BullFrog AI Holdings, Inc. (BFRG)
CIK:        0001829247
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001493152-24-020150
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bullfrog AI and Lieber Institute identify novel drug targets for neuropsychiatric disorders
--------------------------------------------------------------------------------

- Identified dozens of patient clusters for depression, schizophrenia, and bipolar disorder using bfLEAP AI platform.
- Key genes pinpointed for each cluster as potential drug targets; now applying Causal AI for validation.
- Engagement initiated with pharmaceutical companies to secure strategic partnerships in coming quarters.
- Collaboration leverages LIBD's brain data from over 2,800 samples under a three-year exclusive agreement.
- Findings build on September 2023 partnership and January 2024 stratification results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829247/000149315224020150/0001493152-24-020150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829247/000149315224020150/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-020150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer